Abstract
Incidence and Outcome of Neurologic Immune-related Adverse Events Associated with Immune Checkpoint Inhibitors in Patients with Melanoma (S38.007)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have